Class ITerminated in FDA datasetJul 31, 2015

Label reads in part as: "GRAVIOLA EXTRACT***1 FL Oz (30 ml)*** ORIGINAL FORMULA***

Recalling firm: Majopa Industries Corporation

Why it was recalled

Firm's dietary supplements were being promoted for conditions that caused the products to be drugs under the FD&C Act.

Check the codes ↓

The exact product

Label reads in part as: "GRAVIOLA EXTRACT***1 FL Oz (30 ml)*** ORIGINAL FORMULA***Manufactured by: Majopa Industries Corp.*** PRODUCT OF PUERTO RICO,USA". Drug claims in the product label are as follows: "Researchers have found that Extracts from Graviola leaves can produce acetogenins which are extremely effective in the treatment of cancer cells. Graviola extract can works like an antibiotic against cancer cells by stopping growth of the enzymes needed for cell growth. It can be:cellular protector, anti tumorous, antiviral. Also can be used as: Digestive stimulant, Strengthens immune system, antifungal, tranquilizer".

Check the codes

Compare these FDA-provided codes, lot numbers or dates with the product you have.

Match the product, size and code together. A similar name alone does not identify your batch.

Original FDA code information

02/2020

Recall details

Recall number
F-3245-2015
Event ID
71918
FDA status
Terminated
Initiated
Jul 31, 2015
Reported
Sep 30, 2015
Classified
Sep 22, 2015
Terminated
Mar 29, 2017
Quantity
500 bottles
Location
Guayama, PR, United States
Initiation type
Voluntary: Firm initiated
Notification
Telephone

Where it was distributed

Puerto Rico only

FDA source record · F-3245-2015

Data updated September 16, 2026. View official FDA data ↗

A missing code match is not a guarantee of safety. Follow official FDA and manufacturer guidance.